InvestorsHub Logo
Followers 130
Posts 14996
Boards Moderated 1
Alias Born 06/04/2018

Re: None

Friday, 11/01/2019 1:45:22 PM

Friday, November 01, 2019 1:45:22 PM

Post# of 1106
News: $IMGN ImmunoGen Reports Recent Progress and Third Quarter 2019 Financial Results

Full Mirvetuximab Soravtansine Phase 3 FORWARD I and Initial Phase 1b FORWARD II Triplet Data Presented at ESMO Phase 3 MIRASOL Trial for Mirvetuximab in Ovarian Cancer on Track to Start by Year-End Updated IMGN632 AML and BPDCN Monotherapy Data Accepted as Oral Presentation at A...

Read the whole news IMGN - ImmunoGen Reports Recent Progress and Third Quarter 2019 Financial Results
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IMGN News